Antiplatelet Effect of Ticlopidine After Coronary Stenting
- 1 June 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 29 (7) , 1515-1519
- https://doi.org/10.1016/s0735-1097(97)00073-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Changes in membrane glycoproteins of circulating platelets after coronary stent implantation.Heart, 1996
- Is ticlopidine a necessary component of antiplatelet regimens following coronary artery stentingJournal of the American College of Cardiology, 1996
- Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary palmaz-schatz stentingJournal of the American College of Cardiology, 1996
- Antiplatelet DrugsDrugs, 1995
- 931-111 Platelet Activation and Aggregation by Therapeutic Doses of HeparinJournal of the American College of Cardiology, 1995
- Thrombosis and restenosis after stenting in failed angioplasty: Comparison with elective stentingAmerican Heart Journal, 1994
- Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stentsAmerican Heart Journal, 1993
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKEThe Lancet, 1989
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980